On April 26, 2022, HCA Healthcare, Inc. announced that at its annual general meeting of shareholders held on April 21, 2022, the shareholder proposal regarding lobbying disclosure as described in the Company's 2022 proxy statement was not approved.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
306.7 USD | -2.37% | +0.52% | +13.30% |
04-26 | Transcript : HCA Healthcare, Inc., Q1 2024 Earnings Call, Apr 26, 2024 | |
04-26 | HCA Healthcare's Q1 Earnings, Revenue Rise; Maintains 2024 Guidance, Quarterly Dividend | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.30% | 81.12B | |
-14.92% | 84.68B | |
+10.92% | 29.4B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-31.75% | 11.77B | |
-1.42% | 11.72B | |
+27.44% | 11.71B | |
-3.97% | 11.66B |
- Stock Market
- Equities
- HCA Stock
- News HCA Healthcare, Inc.
- Declaration of Voting Results by HCA Healthcare, Inc